MAPT and Alzheimer disease: To investigate the effects of GPF on the degradation of AD-associated pathological proteins, we conducted cell viability assays and fluorescence microscopy in PC-12 ​cells expressing pEGFP-N1-APP, pRK5-EGFP-Tau, and pRK5-EGFP-Tau-P301L.